Credits Available: 4.75 AMA PRA Category 1 Credit™/ MOC Points

Description: This interactive program equips neurology providers with practical strategies to improve care for patients with myasthenia gravis. Grounded in real-world clinical challenges, the content focuses on early identification of high-risk patients, individualized treatment planning, and effective integration of newly approved and emerging therapies. Participants will gain insights that can be immediately applied to enhance outcomes across the spectrum of myasthenia gravis severity.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: MD, DO, Physician Associate/Assistant, Nurse Practitioner
Target Specialties: Neurology, Neuromuscular, Physiatry/Rehabilitation, Neuroimmunology

Aaron Zelikovich

Lenox Hill Hospital
Attending Neurologist

My journey in neuromuscular disorders began in 2013 as a volunteer in the MDA Clinic at Lurie Children's in Chicago. I worked with children with Spinal Muscular Atrophy (SMA) and Duchenne Muscular Dystrophy (DMD) as a clinical research coordinator on pivotal Phase 3 clinical trials for Spinraza, Eteplirsen, and Deflazacort.

My passion for clinical care and therapeutic development evolved as a medical student, and my focus expanded to include children and adults with neuromuscular disorders. I completed my adult neurology residency at Weill Cornell and fellowship in neuromuscular disorders at Penn.

As a practicing neurologist, I'm fortunate to help care for neuromuscular patients in New York City and the greater tri-state area. My research interests include genetic myopathies (DMD, LGMD, and more), young adults with SMA, Myasthenia Gravis, and hereditary neuropathy (hATTR, CMT). My expertise lies in clinical diagnosis, developing updated standard care guidelines, and clinical trials to improve mobility and strength in patients with neuromuscular disorders.